EPISODE · Dec 31, 2024 · 48 MIN
Episode 47 - Marc Lajoie, CEO at Outpace Bio
from Few & Far Between: How Biotech Gets Built · host Chris O'Brien
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells. Tune in today!
What this episode covers
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells. Tune in today!
NOW PLAYING
Episode 47 - Marc Lajoie, CEO at Outpace Bio
No transcript for this episode yet
Similar Episodes
Feb 1, 2025 ·168m
Aug 7, 2024 ·58m
Jun 15, 2022 ·8m